Novartis Pharmaceuticals to pay $4.4 million to resolve Medicaid fraud allegations

BALTIMORE, MD—Maryland Attorney General Brian E. Frosh on Wednesday announced that Maryland will receive more than $4.4 million to resolve allegations that Novartis Pharmaceuticals Corporation (Novartis) paid kickbacks to health care practitioners in the form of cash, meals, entertainment, and honoraria payments to induce them to prescribe various medications that treat hypertension or Type 2 Diabetes.

“This is not the first time a pharmaceutical company has paid kickbacks to doctors,” said Attorney General Frosh. “This settlement should be a clear message to drug manufacturers. We are watching, and we will pursue those who attempt to defraud our state.”

From January 2002 through November 2011, it is alleged that Novartis paid kickbacks to doctors to prescribe Lotrel, Valturna, Starlix, Tekamlo, Diovan HCT, Tekturna HCT, and Exforge HCT, and that between January 2010 and November 2011, Novartis did the same for the drugs Exforge, Diovan and Tekturna.

Source: Novartis Pharmaceuticals to pay $4.4 million to resolve Medicaid fraud allegations / NottinghamMD.com

Leave a Reply

Your email address will not be published. Required fields are marked *